PharmaShots | Incisive News in 3 Shots

Subscribe Now

Biotherapeutics Portfolio

Exelixis Acquires GamaMabs' Oncology Antibody Program to Expand its Biotherapeutics Portfolio

Exelixis Acquires GamaMabs' Oncology Antibody Program to Expand its Biotherapeutics Portfolio

May 5, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us